Genworth Financial heads into its May 20 earnings date with a notable divergence: options traders have shifted decisively toward calls while short sellers sit at their lowest positioning in months.
The clearest signal is in options. The put/call ratio has dropped to 0.19 — well below its 20-day average of 0.24 and more than 1.3 standard deviations beneath it. That makes the current reading one of the most call-skewed in the past year, with the 52-week low at 0.10 and the high at 0.44. The directional shift is a sharp reversal from March, when PCR ran near 0.40. Options traders are leaning bullish, not hedging for downside.
Short interest tells a more muted story. At 1.8% of the free float, positioning is modest — and bears have been retreating. SI fell roughly 11% over the past month, from a peak of around 8.2 million shares in early April to 7.25 million now. That April spike reversed quickly after mid-month, with shorts cutting exposure steadily through late April and into May. The borrow market reflects the same ease: cost to borrow runs at just 0.46%, and while that's up 43% over the past month, the absolute level remains negligible. Availability is loose — there is no squeeze pressure here, and the lending market shows no stress signal worth trading on.
Keefe, Bruyette & Woods — the only active coverage on the name — reinstated its Outperform rating in late March with a $10.50 target, implying roughly 18% upside to the current price of $8.87. Ryan Krueger has steadily ratcheted his target higher over the past year, from $8.00 last April through $9.00, $9.50, $10.00, and now $10.50. That consistent upward revision reflects improving confidence in the Enact mortgage insurance segment, which the bull case points to as a structural grower: 17% market share, 2–3% annual in-force growth, and ROEs running 11–13%. The bear case centres on legal tail risk, specifically the $850 million AXA mis-selling liability, which clouds the holding company's capital return story even as leverage has been cut sharply and buybacks have topped $590 million since 2022. The short score of 30.8 sits well into the lower half of the universe, consistent with this being a low-conviction short at current levels.
Institutional ownership is stable and concentrated. BlackRock holds 15.1% and added nearly 840,000 shares in its most recent filing. Vanguard and Dimensional hold a further 18% combined. Thomas McInerney — the company's CEO — holds 1.4% and added 361,000 shares as recently as early March, a sign of continued alignment with shareholders even if the overall insider picture is mixed (the CFO and a divisional CEO both made small sales on February 26 alongside routine award grants).
Peer performance this week leaned negative across the insurance complex, with CNA off 8.6%, L down 5.5%, and SIGI falling 4%. Against that backdrop, GNW's 1.6% weekly decline looks relatively contained. CNO edged up 2.1%, the only peer in the green.
With earnings confirmed for May 20, the setup heading into the print is one of low short pressure, call-skewed options, and a sole analyst firmly in the bull camp — the next conversation will likely centre on Enact's in-force trends and any update on the AXA litigation timeline.
See the live data behind this article on ORTEX.
Open GNW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
